Time for action: A canadian proposal for primary prevention of type 2 diabetes mellitus

Canadian Journal of Diabetes

Volumn 36, Issue 2, 2012, Pages 44-49

  McManus, Ruth ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLITAZONE DERIVATIVE; METFORMIN; TETRAHYDROLIPSTATIN;

ARTICLE; BEHAVIOR CHANGE; BODY MASS; CANADA; EXERCISE; HEALTH CARE; HEALTH CARE SYSTEM; HEALTH PERSONNEL ATTITUDE; HEALTH PROGRAM; HEALTH PROMOTION; HIGH FIBER DIET; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOCIAL MARKETING;

EID: 84872374890     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2012.04.006     Document Type: Article

References (42)

1. Canadian Diabetes Association. Diabetes: Canada at the tipping pointdcharting a new path. 2011.
2. Canadian Diabetes Association. Diabetes: Canada at the tipping pointdcharting a new path. 2011; 5.
3. Canadian Diabetes Association. An economic tsunami: the cost of diabetes in Canada. (http://www.diabetes.ca/economicreport/). 2009.
4. Ohinmea A, Schopflocher D, Jacobs P, et al. A population-based analysis of health behaviors, chronic diseases and associated costs. Chronic Dis Can 2006;27:17-24.
5. American Diabetes Association. Economic Costs of diabetes in the US in 2007. Diabetes Care 2008;31:596-615.
6. Lightwood J, Bibbins-Domingo K, Coxson P, et al. Forecasting the future economic burden of current adolescent overweight: An estimate of the coronary heart disease policy model. Am J Public Health 2009;99:2230-7.
7. Herman WH. The economics of diabetes prevention. Med Clin North Am 2011; 95:373-84.
8. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
9. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The DaQing IG T and diabetes study. Diabetes Care 1997;20:537-44.
10. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
11. Wycherley TP, Mohr P, Noakes M, et al. Self-reported facilitators of, and impediments to maintenance of healthy lifestyle behaviours following a supervised research-based lifestyle intervention programme in patients with type 2 diabetes. Diabet Med 2012;29:632-9.
12. McManus R, Stitt L, Bargh G. Population survey for diabetes knowledge and protective behaviors. Can J Diabetes 2006;30:256-63.
13. Wycherley TP, Mohr P, Noakes M, et al. Self-reported facilitators of, and impediments to maintenance of healthy lifestyle behaviors following a supervised research-based lifestyle intervention programme in patients with type 2 diabetes. Diabet Med 2011;10:1464-91.
14. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31(Suppl): S55-60.
15. Lindstrom J, Neumann A, Sheppard KE, et al. Time for action to prevent diabetesdThe IMAGE toolkit for diabetes prevention in Europe. Horm Metab Res 2010;42(Suppl 1):S37e55.
16. Narayan KM, Benjamin E, Gregg EW, et al. Diabetes translation research: where are we and where do we want to be? Ann Intern Med 2004;140:958e63.
17. Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: Shaped by global drivers and local environments. Lancet 2011;378:804e14.
18. Finegood DT, Merth TDN, Rutter H. Implications of the Foresight Obesity System Map for solutions to childhood obesity. Obesity 2010;18(Suppl 1):S13-6.
19. He M, Clarson CL, Callaghan C, et al. Childhood overweight and obesity management: A national perspective of primary health care providers' views, practices, perceived barriers and needs. Paediatr Child Health 2010;15: 419-26.
20. Colby SE, Johnson L, Scheett A, et al. Nutrition marketing on food labels. J Nutr Educ Behav 2010;42:92-8.
21. McBride PE, Einerson JA, Grant H, et al. Putting the Diabetes Prevention Program into Practice: A program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus. J Nutr Health Aging 2008;12:745S-9S.
22. Baumann A, Finegood DT, Matsudo V. International perspectives on the physical inactvity crisisdStructural solutions over evidence generation? Prev Med 2009;49:309e12.
23. Wu XY, Ohinmaa A, Veugelers PJ. Diet quality, physical activity, body weight and health-related quality of life among grade 5 students in Canada. Public Health Nutr 2011;4:1e7.
24. Tremblay MS, Craig CL. ParticipACTION: overview and introduction of baseline resaerch on the "new" participACTION. Int J Behav Nutr Phys Act 2009;9:84.
25. Chaisson JL, Josse RG, Gomis R, et al. Acarbose for the prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002;359:2072e7.
26. Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155e61.
27. Ziang AH, Peters RK, Kjos SL, et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 2006;55:517-22.
28. Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality and prediabetes prevalence. Popul Health Metr 2010;8:29.
29. Church TS, Thomas DM, Tudor-Locke C, et al. Trends over 5 decades in US occupation-related physical activity and their associations with obesity. PLoS 2011;6:e19657.
30. Steenhuis IH, Vermeer WM. Portion size: review and framework for interventions. Int J Behav Phys Act 2009;6:58.
31. Hu FB, Li TY, Colditz GA, et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003;289:1785e91.
32. Mela DJ. Determinants of food choice: relationships with obesity and weight control. Obes Res 2001;9(Suppl 4):249S-55S.
33. Gilhooly CH, Das SK, Golden JK, et al. Food cravings and energy regulation: The characteristics of craved foods and their relationship with eating behaviors and weight change during 6 months of dietary energy restriction. Int J Obes 2007; 12:1849e58.
34. Korkiakangas E, Tannila AM, Keinanen-Kiukaanniemi S. Motivation to physical activity among adults with high risk of type 2 diabetes who participated in the Oulu substudy of the Finnish Diabetes Prevention Study. Health Soc Care Community 2011;19:15-22.
35. Genuth S. Insights from the Diabetes Control and Complications Trial/Epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract 2006;12(Suppl):34-41.
36. Holman RR, Paul SK, Bethel MA, et al. A 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577e89.37.
37. Pirani S, Reizes T. The Turning Point Social Marketing National Excellence Collaborative: integratingsocial marketing into routine public health practice. J Public Health Manage Pract 2005;11:131-8.
38. McManus R, Giroux I, Zhou A, et al. Characteristics of women with recent gestational diabetes mellitus attending a postpartum diabetes prevention seminar. Can J Diabetes 2012;36:68e70.
39. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med 2007;357:370e9.
40. Fowler JH, Christakis NA. Diabetes prevention dynamic spread of happiness in a large social network: longitudinal analysis over 20 years in the Framingham Heart Study. BMJ 2008;337:a2338.
41. Goldenberg RM, Cheng AYY, Punthakee Z, et al. Use of glycated hemoglobin (A1C) in the diagnosis of Type 2 diabetes mellitus in adults. Can J Diabetes 2011;35:247-9.
42. American Diabetes Association. Clinical practice recommendations 2012. Diabetes Care 2012;35(Suppl):S64-71